KRYS — KRYSTAL BIOTECH INC

Ownership history in Freestone Grove Partners LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in KRYSTAL BIOTECH INC (KRYS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 2,031 +136 +7.2% 0.00% $359K $176.53
2025 Q2 INITIATED 1,895 — — 0.00% $260K $137.46
% of Fund (quarterly)    KRYS price (monthly, adj. close)

Other funds also holding KRYS

As of 2025 Q4 — sorted by position size

Redmile Group, LLC 3Y 7Y 12.3% S Squared Technology, LLC 3Y 7Y 9.19% Soleus Capital Management, L.P. 3Y 8.56% Avoro Capital Advisors LLC 3Y 7Y 7.0% Evolutionary Tree Capital Management, LLC 3Y 4.81% Frazier Life Sciences Management, L.P. 3Y 3.23% Atle Fund Management AB 3Y 7Y 2.66% Biondo Investment Advisors, LLC 3Y 7Y 2.03% Bellevue Group AG 3Y 7Y 1.92% Hood River Capital Management LLC 3Y 7Y 1.66%
← Back to Freestone Grove Partners LP Holdings